Four collaborative studies are proposed for execution in San Francisco in New York. Research will be conducted that examines: (1) Knowledge of AIDS risk factors, and participation in risky behaviors, among intravenous drug users (IVDUs). (2) Seroprevalence of antibodies to the HTLV-III retrovirus. (3) The psychological impact of knowledge of seropositivity. (4) Factors that may mediate successful dissemination and utilization of AIDS risk-reduction messages for specific sub-populations of IVDUs. Approximately 1,200 IVDUs will be examined each year in San Francisco (800 from treatment programs and 400 out-of-treatment individuals). About 400 IVDUs per year will be examined in New York.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004212-02
Application #
3209555
Study Section
(SRCD)
Project Start
1986-09-30
Project End
1989-08-31
Budget Start
1987-09-30
Budget End
1988-08-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Youth Projects, Inc.
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94117
Hahn, J A; Vranizan, K M; Moss, A R (1997) Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immune Defic Syndr Hum Retrovirol 15:157-64
Kral, A H; Watters, J K; Lifson, A R et al. (1995) Concordance of PCR and antibody results from HIV testing of injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol 10:381-5
Lewis, D K; Watters, J K (1994) Sexual behavior and sexual identity in male injection drug users. J Acquir Immune Defic Syndr 7:190-8
Moss, A R; Vranizan, K; Gorter, R et al. (1994) HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 8:223-31
Watters, J K (1994) Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. J Acquir Immune Defic Syndr 7:1276-81
Watters, J K; Estilo, M J; Clark, G L et al. (1994) Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 271:115-20
Watters, J K; Cheng, Y T; Lorvick, J J (1991) Drug-use profiles, race, age, and risk of HIV infection among intravenous drug users in San Francisco. Int J Addict 26:1247-61
Lewis, D K; Watters, J K (1991) Sexual risk behavior among heterosexual intravenous drug users: ethnic and gender variations. AIDS 5:77-83
Lewis, D K; Watters, J K; Case, P (1990) The prevalence of high-risk sexual behavior in male intravenous drug users with steady female partners. Am J Public Health 80:465-6
Lewis, D K; Watters, J K (1989) Human immunodeficiency virus seroprevalence in female intravenous drug users: the puzzle of black women's risk. Soc Sci Med 29:1071-6

Showing the most recent 10 out of 11 publications